IMEXF (Imagin Medical) Other Operating Expense: $0.12 Mil (TTM As of Jun. 2023)


What is Imagin Medical Other Operating Expense?

Imagin Medical IMEXF -99.00% Other Operating Expense is $0.12 Mil as of Jun. 2023.

Imagin Medical's Other Operating Expense for the three months ended in Jun. 2023 was $0.04 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.12 Mil.

Imagin Medical's quarterly Other Operating Expense declined from Dec. 2022 ($0.03 Mil) to Mar. 2023 ($0.03 Mil) but then increased from Mar. 2023 ($0.03 Mil) to Jun. 2023 ($0.04 Mil).

Imagin Medical's annual Other Operating Expense declined from Sep. 2020 ($0.02 Mil) to Sep. 2021 ($0.02 Mil) but then increased from Sep. 2021 ($0.02 Mil) to Sep. 2022 ($0.04 Mil).

Imagin Medical Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Other Operating Expense Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.04

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.03 0.03 0.04

Imagin Medical Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.12 Mil mean?
Imagin Medical (IMEXF) has a Other Operating Expense of $0.12 Mil as of Jun. 2023. Other operating expenses that a company records on its income statement. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's Other Operating Expense too high?
Imagin Medical's current Other Operating Expense is $0.12 Mil.
How does Imagin Medical's Other Operating Expense compare to ABT and SYK?
Imagin Medical's Other Operating Expense of $0.12 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Imagin Medical and its competitors. Imagin Medical's current Other Operating Expense is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Other Operating Expense of $0.12 Mil. The current Other Operating Expense is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Other Operating Expense is $0.12 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.